Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Ecuador

Low-Margin, Low Growth Cancer Treatment Market

August 2012 | Industry Trend Analysis

BMI View: The comparably moderate cancer burden in Ecuador, the limited pharmaceutical market size and below regional average per capita spending on drugs and healthcare make the South American country unattractive to foreign anti-cancer drugmakers and medical device companies for cancer diagnosis and treatment. BMI believes that the majority of demand in Ecuador for cancer-treatment will be affordable, generic drugs imported from regional neighbours and low-margin diagnostics and therapeutics interventions.

To read the full article, please choose one of the following options:

Subcribers please log in